Improving antigenic peptide vaccines for cancer immunotherapy using a dominant tumor-specific T cell receptor

Journal of Biological Chemistry

Volumn 288, Issue 46, 2013, Pages 33213-33225

  Buhrman, Jonathan D ^a   Jordan, Kimberly R ^a   Munson, Daniel J ^a   Moore, Brandon L ^a   Kappler, John W ^a,b   Slansky, Jill E ^a  

^a UNIVERSITY OF COLORADO SCHOOL OF MEDICINE   (United States)

^b DEPARTMENT OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIGENIC PEPTIDES; CANCER IMMUNOTHERAPY; HIGH AFFINITY; PEPTIDE LIBRARY; PEPTIDE MIMICS; T CELL RECEPTOR; TUMOR ANTIGEN; TUMOR PROTECTION;

ANTIGENS; CELL MEMBRANES; CLONE CELLS; CYTOLOGY; DISEASES; PEPTIDES; VACCINES;

TUMORS;

PEPTIDE VACCINE; T LYMPHOCYTE RECEPTOR;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CANCER IMMUNIZATION; CANCER IMMUNOTHERAPY; CANCER PREVENTION; CELLULAR IMMUNITY; COLON CARCINOMA; CONTROLLED STUDY; DRUG ANTIGENICITY; EX VIVO STUDY; FEMALE; IN VIVO STUDY; MOUSE; NONHUMAN; PEPTIDE LIBRARY; PRIORITY JOURNAL; SEQUENCE ANALYSIS; T LYMPHOCYTE;

ANTIGEN; PEPTIDE ARRAYS; T CELL; T CELL RECEPTOR; TUMOR IMMUNOLOGY; VACCINES;

ANIMALS; ANTIGENS, NEOPLASM; CANCER VACCINES; IMMUNOTHERAPY; MICE; MICE, INBRED BALB C; NEOPLASM PROTEINS; NEOPLASMS; PEPTIDE LIBRARY; RECEPTORS, ANTIGEN, T-CELL;

EID: 84887853384     PISSN: 00219258     EISSN: 1083351X     Source Type: Journal    
DOI: 10.1074/jbc.M113.509554     Document Type: Article

References (59)

1. Wilson, R. K., Lai, E., Concannon, P., Barth, R. K., and Hood, L. E. (1988) Structure, organization and polymorphism of murine and human T-cell receptor α and β chain gene families. Immunol. Rev. 101, 149-172
2. Haskins, K., Kubo, R., White, J., Pigeon, M., Kappler, J., and Marrack, P. (1983) The major histocompatibility complex-restricted antigen receptor on T cells. I. Isolation with a monoclonal antibody. J. Exp. Med. 157, 1149-1169
3. Colf, L. A., Bankovich, A. J., Hanick, N. A., Bowerman, N. A., Jones, L. L., Kranz, D. M., and Garcia, K. C. (2007) How a single T cell receptor recognizes both self and foreign MHC. Cell 129, 135-146
4. Kersh, G. J., and Allen, P. M. (1996) Structural basis for T cell recognition of altered peptide ligands. A single T cell receptor can productively recognize a large continuum of related ligands. J. Exp. Med. 184, 1259-1268
5. Wooldridge, L., Ekeruche-Makinde, J., van den Berg, H. A., Skowera, A., Miles, J. J., Tan, M. P., Dolton, G., Clement, M., Llewellyn-Lacey, S., Price, D. A., Peakman, M., and Sewell, A. K. (2012) A single autoimmune T cell receptor recognizes more than a million different peptides. J. Biol. Chem. 287, 1168-1177
6. Adams, J. J., Narayanan, S., Liu, B., Birnbaum, M. E., Kruse, A. C., Bowerman, N. A., Chen, W., Levin, A. M., Connolly, J. M., Zhu, C., Kranz, D. M., and Garcia, K. C. (2011) T cell receptor signaling is limited by docking geometry to peptide-major histocompatibility complex. Immunity 35, 681-693
7. Macdonald, W. A., Chen, Z., Gras, S., Archbold, J. K., Tynan, F. E., Clements, C. S., Bharadwaj, M., Kjer-Nielsen, L., Saunders, P. M., Wilce, M. C., Crawford, F., Stadinsky, B., Jackson, D., Brooks, A. G., Purcell, A. W., Kappler, J. W., Burrows, S. R., Rossjohn, J., and McCluskey, J. (2009) T cell allorecognition via molecular mimicry. Immunity 31, 897-908
8. Ding, Y. H., Smith, K. J., Garboczi, D. N., Utz, U., Biddison, W. E., and Wiley, D. C. (1998) Two human T cell receptors bind in a similar diagonal mode to the HLA-A2/Tax peptide complex using different TCR amino acids. Immunity 8, 403-411
9. Sewell, A. K. (2012) Why must T cells be cross-reactive? Nat. Rev. Immunol. 12, 669-677
10. Miles, J. J., Douek, D. C., and Price, D. A. (2011) Bias in the αβ T-cell repertoire. Implications for disease pathogenesis and vaccination. Immunol. Cell Biol. 89, 375-387
11. Chastain, E. M., and Miller, S. D. (2012) Molecular mimicry as an inducing trigger for CNS autoimmune demyelinating disease. Immunol. Rev. 245, 227-238
12. Enouz, S., Carrié, L., Merkler, D., Bevan, M. J., and Zehn, D. (2012) Autoreactive T cells bypass negative selection and respond to self-antigen stimulation during infection. J. Exp. Med. 209, 1769-1779
13. Miller, J. F., and Basten, A. (1996) Mechanisms of tolerance to self. Curr. Opin. Immunol. 8, 815-821
14. Liu, G. Y., Fairchild, P. J., Smith, R. M., Prowle, J. R., Kioussis, D., and Wraith, D. C. (1995) Low avidity recognition of self-antigen by T cells permits escape from central tolerance. Immunity 3, 407-415
15. McWilliams, J. A., Sullivan, R. T., Jordan, K. R., McMahan, R. H., Kemmler, C. B., McDuffie, M., and Slansky, J. E. (2008) Age-dependent tolerance to an endogenous tumor-associated antigen. Vaccine 26, 1863-1873
16. Hogquist, K. A., Baldwin, T. A., and Jameson, S. C. (2005) Central tolerance. Learning self-control in the thymus. Nat. Rev. 5, 772-782
17. Ohlén, C., Kalos, M., Cheng, L. E., Shur, A. C., Hong, D. J., Carson, B. D., Kokot, N. C., Lerner, C. G., Sather, B. D., Huseby, E. S., and Greenberg, P. D. (2002) CD8(+) T cell tolerance to a tumor-associated antigen is maintained at the level of expansion rather than effector function. J. Exp. Med. 195, 1407-1418
18. Tam, R. C., Fedoseyeva, E. V., Moskalenko, M., Garovoy, M. R., and Benichou, G. (1996) T cell tolerance is influenced by concomitant T cell recognition of cross-reactive self-peptides. J. Immunol. 156, 3765-3771
19. Zügel, U., Wang, R., Shih, G., Sette, A., Alexander, J., and Grey, H. M. (1998) Termination of peripheral tolerance to a T cell epitope by heteroclitic antigen analogues. J. Immunol. 161, 1705-1709
20. De Visser, K. E., Schumacher, T. N., and Kruisbeek, A. M. (2003) CD8 T cell tolerance and cancer immunotherapy. J. Immunother. 26, 1-11
21. Tang, Y., Lin, Z., Ni, B., Wei, J., Han, J., Wang, H., and Wu, Y. (2007) An altered peptide ligand for naive cytotoxic T lymphocyte epitope of TRP-2(180-188) enhanced immunogenicity. Cancer Immunol. Immunother. 56, 319-329
22. Overwijk, W. W., Tsung, A., Irvine, K. R., Parkhurst, M. R., Goletz, T. J., Tsung, K., Carroll, M. W., Liu, C., Moss, B., Rosenberg, S. A., and Restifo, N. P. (1998) gp100/pmel 17 is a murine tumor rejection antigen. Induction of "self"-reactive, tumoricidal T cells using high-affinity, altered peptide ligand. J. Exp. Med. 188, 277-286
23. de Visser, K. E., Cordaro, T. A., Kessels, H. W., Tirion, F. H., Schumacher, T. N., and Kruisbeek, A. M. (2001) Low-avidity self-specific T cells display a pronounced expansion defect that can be overcome by altered peptide ligands. J. Immunol. 167, 3818-3828
24. Tumenjargal, S., Gellrich, S., Linnemann, T., Muche, J. M., Lukowsky, A., Audring, H., Wiesmüller, K. H., Sterry, W., and Walden, P. (2003) Antitumor immune responses and tumor regression induced with mimotopes of a tumor-associated T cell epitope. Eur. J. Immunol. 33, 3175-3185
25. Ekeruche-Makinde, J., Clement, M., Cole, D. K., Edwards, E. S., Ladell, K., Miles, J. J., Matthews, K. K., Fuller, A., Lloyd, K. A., Madura, F., Dolton, G. M., Pentier, J., Lissina, A., Gostick, E., Baxter, T. K., Baker, B. M., Riz- kallah, P. J., Price, D. A., Wooldridge, L., and Sewell, A. K. (2012) T-cell receptor optimized peptide skewing of the T-cell repertoire can enhance antigen targeting. J. Biol. Chem. 287, 37269-37281
26. Hou, Y., Kavanagh, B., and Fong, L. (2008) Distinct CD8+ T cell repertoires primed with agonist and native peptides derived from a tumorassociated antigen. J. Immunol. 180, 1526-1534
27. Wieckowski, S., Baumgaertner, P., Corthesy, P., Voelter, V., Romero, P., Speiser, D. E., and Rufer, N. (2009) Fine structural variations of αβTCRs selected by vaccination with natural versus altered self-antigen in melanoma patients. J. Immunol. 183, 5397-5406
28. Iero, M., Squarcina, P., Romero, P., Guillaume, P., Scarselli, E., Cerino, R., Carrabba, M., Toutirais, O., Parmiani, G., and Rivoltini, L. (2007) Low TCR avidity and lack of tumor cell recognition in CD8(+) T cells primed with the CEA-analogue CAP1-6D peptide. Cancer Immunol. Immunother. 56, 1979-1991
29. Speiser, D. E., Baumgaertner, P., Voelter, V., Devevre, E., Barbey, C., Rufer, N., and Romero, P. (2008) Unmodified self antigen triggers human CD8 T cells with stronger tumor reactivity than altered antigen. Proc. Natl. Acad. Sci. U.S.A. 105, 3849-3854
30. Cole, D. K., Edwards, E. S., Wynn, K. K., Clement, M., Miles, J. J., Ladell, K., Ekeruche, J., Gostick, E., Adams, K. J., Skowera, A., Peakman, M., Wooldridge, L., Price, D. A., and Sewell, A. K. (2010) Modification ofMHC anchor residues generates heteroclitic peptides that alter TCR binding and T cell recognition. J. Immunol. 185, 2600-2610
31. Zaremba, S., Barzaga, E., Zhu, M., Soares, N., Tsang, K. Y., and Schlom, J. (1997) Identification of an enhancer agonist cytotoxic T lymphocyte peptide from human carcinoembryonic antigen. Cancer Res. 57, 4570-4577
32. Rubio, V., Stuge, T. B., Singh, N., Betts, M. R., Weber, J. S., Roederer, M., and Lee, P. P. (2003) Ex vivo identification, isolation and analysis of tumorcytolytic T cells. Nat. Med. 9, 1377-1382
33. Stuge, T. B., Holmes, S. P., Saharan, S., Tuettenberg, A., Roederer, M., Weber, J. S., and Lee, P. P. (2004) Diversity and recognition efficiency of T cell responses to cancer. PLoS Med. 1, e28
34. Clay, T. M., Custer, M. C., McKee, M. D., Parkhurst, M., Robbins, P. F., Kerstann, K., Wunderlich, J., Rosenberg, S. A., and Nishimura, M. I. (1999) Changes in the fine specificity of gp100(209-217)-reactive T cells in patients following vaccination with a peptide modified at an HLA-A2.1 anchor residue. J. Immunol. 162, 1749-1755
35. Appay, V., Speiser, D. E., Rufer, N., Reynard, S., Barbey, C., Cerottini, J. C., Leyvraz, S., Pinilla, C., and Romero, P. (2006) Decreased specific CD8+ T cell cross-reactivity of antigen recognition following vaccination with Melan-A peptide. Eur. J. Immunol. 36, 1805-1814
36. McMahan, R. H., McWilliams, J. A., Jordan, K. R., Dow, S. W., Wilson, D. B., and Slansky, J. E. (2006) Relating TCR-peptide-MHC affinity to immunogenicity for the design of tumor vaccines. J. Clin. Invest. 116, 2543-2551
37. Slansky, J. E., Rattis, F. M., Boyd, L. F., Fahmy, T., Jaffee, E. M., Schneck, J. P., Margulies, D. H., and Pardoll, D. M. (2000) Enhanced antigen-specific antitumor immunity with altered peptide ligands that stabilize the MHCpeptide-TCR complex. Immunity 13, 529-538
38. Jordan, K. R., McMahan, R. H., Oh, J. Z., Pipeling, M. R., Pardoll, D. M., Kedl, R. M., Kappler, J. W., and Slansky, J. E. (2008) Baculovirus-infected insect cells expressing peptide-MHC complexes elicit protective antitumor immunity. J. Immunol. 180, 188-197
39. Jordan, K. R., McMahan, R. H., Kemmler, C. B., Kappler, J. W., and Slansky, J. E. (2010) Peptide vaccines prevent tumor growth by activating T cells that respond to native tumor antigens. Proc. Natl. Acad. Sci. U.S.A. 107, 4652-4657
40. Jordan, K. R., Buhrman, J. D., Sprague, J., Moore, B. L., Gao, D., Kappler, J. W., and Slansky, J. E. (2012) TCR hypervariable regions expressed by T cells that respond to effective tumor vaccines. Cancer Immunol. Immunother. 61, 1627-1638
41. Crawford, F., Huseby, E., White, J., Marrack, P., and Kappler, J. W. (2004) Mimotopes for alloreactive and conventional T cells in a peptide-MHC display library. PLoS Biol 2, E90
42. Crawford, F., Jordan, K. R., Stadinski, B., Wang, Y., Huseby, E., Marrack, P., Slansky, J. E., and Kappler, J. W. (2006) Use of baculovirus MHC/peptide display libraries to characterize T-cell receptor ligands. Immunol. Rev. 210, 156-170
43. Wang, Y., Rubtsov, A., Heiser, R., White, J., Crawford, F., Marrack, P., and Kappler, J. W. (2005) Using a baculovirus display library to identify MHC class I mimotopes. Proc. Natl. Acad. Sci. U.S.A. 102, 2476-2481
44. Khilko, S. N., Corr, M., Boyd, L. F., Lees, A., Inman, J. K., and Margulies, D. H. (1993) Direct detection of major histocompatibility complex class I binding to antigenic peptides using surface plasmon resonance. Peptide immobilization and characterization of binding specificity. J. Biol. Chem. 268, 15425-15434
45. Balendiran, G. K., Solheim, J. C., Young, A. C., Hansen, T. H., Nathenson, S. G., and Sacchettini, J. C. (1997) The three-dimensional structure of an H-2Ld-peptide complex explains the unique interaction of Ld with β-2 microglobulin and peptide. Proc. Natl. Acad. Sci. U.S.A. 94, 6880-6885
46. Ozato, K., Hansen, T. H., and Sachs, D. H. (1980) Monoclonal antibodies to mouse MHC antigens. II. Antibodies to the H-2Ld antigen, the products of a third polymorphic locus of the mouse major histocompatibility complex. J. Immunol. 125, 2473-2477
47. Liu, C. P., Crawford, F., Marrack, P., and Kappler, J. (1998) T cell positive selection by a high density, low affinity ligand. Proc. Natl. Acad. Sci. U.S.A. 95, 4522-4526
48. Sanchez, P. J., McWilliams, J. A., Haluszczak, C., Yagita, H., and Kedl, R. M. (2007) Combined TLR/CD40 stimulation mediates potent cellular immunity by regulating dendritic cell expression of CD70 in vivo. J. Immunol. 178, 1564-1572
49. Buhrman, J. D., Jordan, K. R., U'ren, L., Sprague, J., Kemmler, C. B., and Slansky, J. E. (2013) Augmenting antitumor T-cell responses to mimotope vaccination by boosting with native tumor antigens. Cancer Res. 73, 74-85
50. Cole, D. K., Pumphrey, N. J., Boulter, J. M., Sami, M., Bell, J. I., Gostick, E., Price, D. A., Gao, G. F., Sewell, A. K., and Jakobsen, B. K. (2007) Human TCR-binding affinity is governed by MHC class restriction. J. Immunol. 178, 5727-5734
51. Bridgeman, J. S., Sewell, A. K., Miles, J. J., Price, D. A., and Cole, D. K. (2012) Structural and biophysical determinants of αβ T-cell antigen recognition. Immunology 135, 9-18
52. Truscott, S. M., Lybarger, L., Martinko, J. M., Mitaksov, V. E., Kranz, D. M., Connolly, J. M., Fremont, D. H., and Hansen, T. H. (2007) Disulfide bond engineering to trap peptides in the MHC class I binding groove. J. Immunol. 178, 6280-6289
53. Seder, R. A., Darrah, P. A., and Roederer, M. (2008) T-cell quality in memory and protection. Implications for vaccine design. Nat. Rev. Immunol. 8, 247-258
54. Almeida, J. R., Sauce, D., Price, D. A., Papagno, L., Shin, S. Y., Moris, A., Larsen, M., Pancino, G., Douek, D. C., Autran, B., Sáez- Cirión, A., and Appay, V. (2009) Antigen sensitivity is a major determinant ofCD8+T-cell polyfunctionality and HIV-suppressive activity. Blood 113, 6351-6360
55. Appay, V., Douek, D. C., and Price, D. A. (2008) CD8 T cell efficacy in vaccination and disease. Nat. Med. 14, 623-628
56. Holler, P. D., Chlewicki, L. K., and Kranz, D. M. (2003) TCRs with high affinity for foreign pMHC show self-reactivity. Nat. Immunol. 4, 55-62
57. Birnbaum, M. E., Dong, S., and Garcia, K. C. (2012) Diversity-oriented approaches for interrogating T-cell receptor repertoire, ligand recognition, and function. Immunol. Rev. 250, 82-101
58. Kedl, R. M., Schaefer, B. C., Kappler, J. W., and Marrack, P. (2002) T cells down-modulate peptide-MHC complexes on APCs in vivo. Nat. Immunol. 3, 27-32
59. Kedl, R. M., Rees, W. A., Hildeman, D. A., Schaefer, B., Mitchell, T., Kappler, J., and Marrack, P. (2000) T cells compete for access to antigenbearing antigen-presenting cells. J. Exp. Med. 192, 1105-1113